Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,720 | -59,810 | -32,290 | 33,390 | 10,570 |
| Depreciation Amortization | 27,850 | 7,150 | 5,640 | 9,420 | 7,600 |
| Other Working Capital | -16,490 | 58,520 | 4,900 | 250 | 1,280 |
| Other Operating Activity | -10,770 | -7,130 | -3,780 | -35,110 | -6,520 |
| Operating Cash Flow | $-24,130 | $-1,270 | $-25,530 | $7,950 | $12,930 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -500 | 13,700 | -2,970 | -1,890 | -1,740 |
| Net Acquisitions | 0 | 0 | 2,230 | 11,890 | -92,640 |
| Other Investing Activity | -590 | 28,300 | 27,160 | -28,650 | -1,160 |
| Investing Cash Flow | $-1,090 | $42,000 | $26,420 | $-18,650 | $-95,540 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 14,200 | -1,190 | -1,310 | -8,570 | 88,920 |
| Financing Cash Flow | $14,200 | $-1,190 | $-1,310 | $-8,570 | $88,920 |
| Exchange Rate Effect | -90 | -580 | 1,330 | 1,350 | -2,780 |
| Beginning Cash Position | 49,220 | 10,270 | 9,350 | 27,260 | 23,730 |
| End Cash Position | 38,100 | 49,220 | 10,270 | 9,350 | 27,260 |
| Net Cash Flow | $-11,120 | $38,950 | $910 | $-17,910 | $3,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,130 | -1,270 | -25,530 | 7,950 | 12,930 |
| Free Cash Flow | -24,130 | -1,270 | -25,530 | 7,950 | 12,930 |